Mission Therapeutics has agreed to divest its phase 2‑ready acute kidney injury candidate MTX652 to Australian renal ...

A recent study published in the Journal of the American Medical Association revealed that acute kidney injury (AKI) in ...

Mission Therapeutics has announced that MTX652, its Phase 2-ready USP30 inhibitor for acute kidney injury, has been acquired by Australian Stock Exchange-listed renal specialist Dimerix in a ...

CT angiography of the abdomen showed occlusion of the proximal left main renal artery with global hypoperfusion of the left kidney (arrow). A ...

Renal ischaemia–reperfusion injury (RIRI) arises when blood flow to the kidney is interrupted and then restored, triggering a cascade of cellular and molecular events that culminate in acute kidney ...

Monsoon illnesses can affect more than your overall health. Know how dengue, UTIs and other seasonal infections may harm the ...

A recent retrospective study published in the Indian Journal of Nephrology in February 2026 reveals that 60.79% of diabetic ...

Capital-efficient strategy focuses on differentiated therapies for cardiac pre- and post-operative critical care and orphan cardiovascular conditionsCompany is exploring development, licensing, and ...

Millions of people with type 2 diabetes take a common class of blood pressure pill called dihydropyridine calcium channel ...

Background Circulatory collapse at hospital arrival represents one of the most severe clinical presentations of ST-segment ...

Months after the contaminated Coldrif cough syrup-induced acute kidney injury claimed the lives of at least 19 children in Parasia town of southern Madhya Prade ...

Researchers evaluated finerenone and empagliflozin for systolic blood pressure reduction in type 2 diabetes and chronic kidney disease.